Mar 28, 2013 | Inside, Your Health
Mount Sinai physicians, nurses, and diabetes educators participated in the American Diabetes Association (ADA) Diabetes Expo on Saturday, March 9, at the Jacob K. Javits Center. The Mount Sinai team of more than 70 volunteers provided free screenings for blood pressure, weight, blood sugar, and cholesterol, as well as eye exams, to approximately 500 individuals. Physicians were on site to interpret the screening results and discuss how participants could take better control of their diabetes.
(more…)
Mar 21, 2013 | Inside
Arthur Klein, MD, a leader in health care management, has been named President of The Mount Sinai Health Network. In this new role, Dr. Klein will oversee The Mount Sinai Medical Center’s growing network of more than one hundred clinical relationships, including eighteen affiliated hospitals, five nursing homes, and twelve physician group practices throughout New York City, and Nassau, Suffolk, and
Westchester counties.
“Dr. Klein is known as an innovator in the evolving health care landscape,” says Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center. “His leadership will help invigorate and integrate our growing network of hospitals, clinical practices, and polyclinics.”
(more…)
Mar 21, 2013 | Inside, Research, Your Health
In a phase I clinical trial, physicians at The Mount Sinai Medical Center have identified the first drug that appears to stop the progression of myelofibrosis, a life-threatening blood cancer. The investigators found that, at low-doses, panobinostat (LBH589) successfully halted and reversed damage to the blood and bone marrow in several of the forty patients enrolled in the trial. Panobinostat, manufactured by Novartis, is a histone deacetylase inhibitor that affects the chromatin structure of malignant cells.
The study, led by Ronald Hoffman, MD, Albert A. and Vera G. List Professor of Medicine, and Director of the Myeloproliferative Disorders Research Program, and John O. Mascarenhas, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), was published online in the January 21, 2013, issue of the British Journal of Haematology.
(more…)
Mar 21, 2013 | Inside
Two years before seeking help
from physicians at The Mount Sinai Medical Center, Rosemary McGinn, 53, was diagnosed with hypoglycemia. She went everywhere with an arsenal of snacks and juices that she ingested frequently to keep her blood sugar from dropping.
“When my sugar would suddenly crash, it was like I was drunk,” she says. “I would become very combative, not knowing what I was saying, and sway back and forth.”
(more…)
Mar 21, 2013 | Cardiology, Inside, Research
Roger J. Hajjar, MD, a pioneering Mount Sinai researcher who has published cutting-edge studies on heart failure, has been named the recipient of the 2013 BCVS Distinguished Achievement Award by the American Heart Association and the Council on Basic Cardiovascular Sciences. Dr. Hajjar, who is The Arthur and Janet C. Ross Professor of Medicine and Director of The Helmsley Trust Translational Research Center, will be honored at the American Heart Association’s Scientific Sessions Annual Conference later this year.
“Dr. Hajjar will receive the award for his groundbreaking contributions to developing gene therapy treatments for cardiac disease,” says Joshua Hare, MD, who is President-elect of the Council on Basic Cardiovascular Sciences. He will also be recognized for his work on behalf of the Council.
(more…)
Mar 21, 2013 | Inside, School
The Graduate Program in Public Health at Icahn School of Medicine at Mount Sinai continues to expand its curriculum with new specialty tracks, an advanced certificate program, and a new name—it was formerly The Master of Public Health Program.
The public health program, which enrolls 60 new students each year, is part of the Graduate School of Biomedical Sciences. Three new courses of study include Biostatistics, Epidemiology, and Health Care Management, which complement the tracks that existed previously: Global Health, Health Promotion & Disease Prevention, Outcomes Research, and Occupational and Environmental Medicine. The courses are designed for students who want a strong foundation in community-based research, and experience in building population-based studies for disease prevention and health promotion.
(more…)
